Anchiano Therapeutics Ltd.
-
Ticker
ANCN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Cambridge, Massachusetts
Anchiano is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer in areas of significant clinical need located in Cambridge, MA. The Company is developing small-molecule pan-mutant-RAS inhibitors and inhibitors of PDE10 and the b-catenin pathway.
REPORT RATINGS
4.8 / 5.0 (64)
Anchiano Therapeutics Ltd. reports have an aggregate usefulness score of 4.8 based on 64 reviews.
Anchiano Therapeutics Ltd.
Most Recent Annual Report
MOST RECENT
2019 Form 10K